Literature DB >> 2834113

Cyclic guanosine monophosphate-enhanced sequestration of Ca2+ by sarcoplasmic reticulum in vascular smooth muscle.

C H Twort1, C van Breemen.   

Abstract

The purpose of this study was to investigate the effects of the intracellular messenger cyclic GMP (cGMP) on sequestration of cytosolic calcium (Ca2+) into the intracellular Ca2+ store (the sarcoplasmic reticulum) of vascular smooth muscle. Using saponin-skinned primary cultures of rat aortic smooth muscle, we investigated the effect of cGMP on 45Ca uptake in monolayers of cells. The intracellular store was loaded with Ca2+ by exposing the skinned cells to a 45Ca-labeled 1-microM free Ca2+-containing solution for varying durations (0-20 minutes). Addition of 10 microM cGMP to six monolayers increased both the initial Ca2+ uptake at 2 minutes (control, 240 +/- 8 pmol Ca2+/10(6) cells; + cGMP 295 +/- 7; mean +/- SEM; n = 6, p less than 0.01) and the final steady-state uptake reached at 20 minutes (control, 0.96 +/- 0.03 nmol Ca2+/10(6) cells; + cGMP 1.12 +/- 0.03, p less than 0.02). This stimulation of uptake was quantitatively similar to that caused by 10 microM cyclic AMP. It occurred at varying ambient cytosolic Ca2+ concentrations (0.1-1.0 microM Ca2+) and was not further enhanced by addition of 10 microM cGMP-dependent protein kinase. The dose-response of stimulation of Ca2+ uptake with cGMP indicated an ED50 of 5 nM cGMP. The release of Ca2+ from the sarcoplasmic reticulum in response to inositol 1,4,5-trisphosphate or caffeine was unaffected by cGMP. We conclude that the relaxation of vascular smooth muscle with cGMP-producing vasodilators is mediated in part by sequestration of cytosolic Ca2+ by the sarcoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834113     DOI: 10.1161/01.res.62.5.961

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  33 in total

Review 1.  Exhaled nitric oxide during exercise.

Authors:  A W Sheel; J Road; D C McKenzie
Journal:  Sports Med       Date:  1999-08       Impact factor: 11.136

2.  Mechanisms of cGMP-dependent mesangial-cell relaxation: a role for myosin light-chain phosphatase activation.

Authors:  G Torrecillas; M L Díez-Marqués; C García-Escribano; R J Bosch; D Rodríguez-Puyol; M Rodríguez-Puyol
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Signals controlling renin release in aglomerular toadfish.

Authors:  H Nishimura; M A Madey
Journal:  Fish Physiol Biochem       Date:  1989-06       Impact factor: 2.794

4.  Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

Authors:  S L Archer; J M Huang; V Hampl; D P Nelson; P J Shultz; E K Weir
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

5.  Endothelium-derived relaxing factor inhibits the formation of inositol trisphosphate by rabbit aorta.

Authors:  D Lang; M J Lewis
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

Review 6.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 7.  Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.

Authors:  L J Ignarro
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

8.  Maxi K+ channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells.

Authors:  J Taniguchi; K I Furukawa; M Shigekawa
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

9.  Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle.

Authors:  H C Parkington; M A Tonta; H A Coleman; M Tare
Journal:  J Physiol       Date:  1995-04-15       Impact factor: 5.182

10.  Cyclic AMP selectively enhances bradykinin receptor synthesis and expression in cultured arterial smooth muscle. Inhibition of angiotensin II and vasopressin response.

Authors:  B S Dixon
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.